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ABSTRACT
The study aimed to investigate the occurrence of carbapenem resistant E. coli and P. aeruginosa in apparently 
healthy, captive blackbucks and leopards of India. Faecal samples of blackbucks (n = 7) and leopards (n = 7) were 
processed to isolate carbapenem resistant E. coli (CRE) and P. aeruginosa (CRP). Forty (leopards n = 26; blackbuck n 
= 14) E. coli and two P. aeruginosa (blackbuck n = 2) samples were isolated from the faecal samples (n = 14). Eleven 
carbapenem resistant isolates were recovered, of which 10 were CRE and one was CRP. The minimum inhibitory 
concentration (MIC) was determined for meropenem for carbapenem resistant isolates and was between 8 and 64 
μg/mL. All the CRE and CRP were phenotypically multidrug resistant, and six CRE were extended-spectrum beta-
lactamases (ESBL) producers. On genotypic screening, seven CRE and one CRP were positive for the blaNDM 
carbapenemase gene. Efflux pump-mediated carbapenem resistance was noticed in four CRE isolates (36.4%, 4/11). 
Of the six ESBL producing CRE, four isolates carried blaCTX-M-1 genes. The CRE isolates also harbored blaTEM-1, 
blaAmpC, qnrA, qnrB, qnrS, tetA, tetB and sul1 resistance genes. On Shiga toxin virulence screening, Stx1, Stx2 
genes were detected in two and one isolates, respectively. Plasmid typing of CRE revealed that the blaNDM genes 
were carried on an Incl1 plasmid. The plasmid multilocus sequence typing (pMLST) of the isolates showed the 
Sequence Type (ST) 297. The occurrence of carbapenem resistance bacteria in captive wildlife should be a major 
public health priority.
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Antibacterial screening of E. coli and P. 
aeurogenosa isolates. Reference strains ( GenBank 
accession number KT853018, KT867018, 
KT867020 and KT867021) obtained from the 
Division of Epidemiology, Indian Veterinary 
Research Institute, Izatnagar repository, were used 
in this study as positive controls. The recovered 
E. coli (n = 40) and P. aeruginosa (n = 2) isolates 
were tested for antibacterial susceptibility patterns 
against meropenem (MEM, 10 μg), imipenem (IMP, 
10 μg) and ertapenem (ETP, 10 μg) disks (BD, 
Sparks, MD, USA) along with metal ion chelator 
ethylene diamine tetra acetic acid (EDTA; 1900 
mg), to screen for metallo beta-lactamase (MBL) 
production (PRUTHVISHREE et al., 2017). A 
keyhole reaction between the carbapenem drug and 
EDTA was considered positive for MBL. 
For phenotypic identification of ESBL 
producers, the combination disc method was used 
(ANDREWS, 2003) by cefotaxime and ceftazidime, 
with and without clavulanic acid. Once the zone of 
inhibition between the combination disc and the 
corresponding single antibacterial disc differed 
by ≥5 mm, the isolate was identified as an ESBL 
producer. The isolates were further confirmed as 
ESBL producers using the E-test. The isolates 
were also screened for aztreonam (ATZ, 30 μg), 
chloramphenicol (C, 30 μg), ceftriaxone (CTR, 
30 μg), cefpodoxime (CPD, 10 μg), ceftazidime 
(CAZ, 30 μg), cefotaxime (CTX, 30 μg), cefepime 
(CPM, 30 μg), cefixime (CFM, 5 μg), cefoxitin 
(FOX, 30 μg), piperacillin - tazobactam (TZP, 
100/10 μg), cefotaxime/clavulanic acid (30/10 μg), 
tetracycline (TE, 30 μg), nitrofurantoin (F/M, 300 
μg), gentamicin (GEN, 10 μg), co-trimoxazole 
(COT, 25 μg), ciprofloxacin (CIP, 5 μg) and 
norfloxacin (NX, 10 μg) by the disc diffusion 
method. The CLSI, 2014 breakpoints were used for 
interpretation of the susceptibility pattern. The MIC 
against meropenem, ceftriaxone, cefotaxime was 
determined using E-test strips (HiMedia, Mumbai, 
India) for the carbapenem resistant isolates (n = 11).
PCR for carbapenemase producing genes and 
sequencing. PCR was carried out targeting beta-
lactamase (PRUTHVISHREE et al., 2017), major 
Introduction
Antimicrobial resistance is an emerging global 
threat and needs immediate attention. It is a complex 
and multidimensional problem involving humans, 
animals, and the environment. The intensive and 
indiscriminate use of antimicrobials in humans 
and animals has resulted in the emergence of 
antimicrobial resistance (AMR) in humans, 
animals, and the environment (BERENDONK et 
al., 2015). Transmission of carbapenem resistant 
Enterobacteriales between animals and exposed 
humans has been reported (KOCK et al., 2018).
Carbapenems are one of the most important 
groups of antimicrobials, and are considered as 
the last line of drugs for the treatment of severe 
infections. Carbapenem resistance in animals 
appears to have developed and disseminated as a 
consequence of clinical carbapenem use in human 
medicine (MURUGAN et al., 2019). The present 
study was planned to investigate the occurrence and 
to characterize carbapenem resistant E. coli and P. 
aeruginosa in captive blackbucks and leopards of 
India.
Materials and methods
Sample collection. A cross-sectional study was 
conducted during 2015-16 in a zoo for screening 
antibacterial resistance in apparently healthy captive 
blackbucks and leopards. The representative faecal 
samples from blackbucks (n = 7) and leopards (n = 
7) were collected in sterile transport swabs. 
Isolation and identification of E. coli and P. 
aeruginosa. Each faecal swab was pre-enriched 
in buffered peptone water (incubation at 37 °C 
for 2-4h) 37 °C, the inoculums were streaked 
on Hektoen enteric agar (HEA) plates, and on 
HEA yellow colour colonies were considered 
to be presumptive E. coli, while the transparent 
non-fermenting colonies were considered to be 
presumptive Pseudomonas. From each plate, 3-4 
presumptive E. coli and Pseudomonas colonies 
were taken out and the respective colonies were 
streaked on MacConkey agar plates with imipenem 
(0.5 mg/L) added, and incubated at 37 °C overnight 
(PRUTHVISHREE et al., 2017). Subsequently, the 
characteristic isolated colonies were extracted for 
identification by biochemical tests.
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carbapenemase (POIREL et al., 2011), Shiga toxin 
virulence markers (PATON and PATON, 1998), 
sulphonamide resistance (KERRN et al., 2002), and 
plasmid mediated quinolone resistance (PMQR) 
determinants (CIESIELCZUK et al., 2013) and 
tetracycline resistance (MAYNARD et al., 2004) 
genes. The reactions were optimized individually 
in 25 µL volumes with 10 picomoles of each 
primer. The PCR amplicon from all reactions was 
electrophoresed in 0.5 X TBE buffer using 1.5% 
agarose gel, and visualized under UV illumination 
(Syngene, USA). The PCR amplicons (blaNDM 
and blaAmpC) were purified and sequenced 
by commercial sequencing services (Eurofins, 
Bengaluru, India). The sequencing results were 
obtained and homology searches were performed 
using the BLAST algorithm (http://blast.ncbi.
nlm.nih.gov/Blast.cgi). The sequence data were 
submitted to GenBank, and the accession numbers 
were obtained.
Plasmid replicon and multilocus sequence 
(MLST) typing of E. coli isolates. The plasmid DNA 
was extracted from E. coli by a Qiagen Miniprep 
kit (Qiagen, India) from the blaNDM positive E. 
coli. Plasmids were assigned to incompatibility 
groups by multiplex PCR (JOHNSON et al., 
2007). After assigning the incompatibility groups, 
the corresponding plasmid MLST was performed 
using specific primers (GARCIA-FERNANDEZ 
et al., 2018) and sequenced by the Sanger method 
(Eurofins India Ltd, Bengaluru). The sequences 
were edited using BioEdit v7.0.5 and examined 
on the plasmid MLST website (https://pubmlst.
org/bigsdb?db = pubmlst_plasmid_seqdef) for the 
allelic profile, sequence type, and clonal complex. 
Assay for overexpressed efflux pumps. Isolates 
not showing carbapenemase mediated resistance 
were screened for the presence of an active efflux 
pump by the ethidium bromide agar cartwheel 
method (PRUTHVISHREE et al.,2017).
Results and discussion 
From the faecal samples, forty (leopards n = 26; 
blackbucks n = 14) E. coli and two P. aeruginosa 
(blackbucks n = 2) were isolated. From each animal 
swab, 3-4 presumptive E. coli and Pseudomonas 
colonies were picked up and characterized. The E. 
coli isolates from leopards (n = 26) and blackbucks 
(n = 14) screened for carbapenem resistance 
revealed that nine E. coli from leopards and one E. 
coli from blackbucks were carbapenem resistant. 
Pseudomonas aeruginosa could only be isolated 
from blackbuck faecal samples. The CRE (n = 9) 
from leopards were resistant to MEM (9/9, 100%) 
followed by IMP (8/9, 88.9%) and ETP (6/9, 
66.7%). Similarly the CRE (n = 1) and CRP (n = 1) 
from blackbucks were resistant to MRP. 
In addition, the CRP (n = 1) was also resistant 
to IMP and ETP. The reason for the higher MEM 
resistance might be associated with the increased 
clinical use of meropenem in India (GANDRA et 
al., 2016). Of the carbapenem resistant isolates (n = 
11), seven CRE ( n = 6 from leopards and n = 1 from 
blackbucks) and one CRP from blackbucks showed 
the keyhole reaction with EDTA, indicating metallo 
beta-lactamase (MBL) production. The minimum 
inhibitory concentration (MIC) for meropenem of 
the carbapenem resistant isolates ranged from 8 to 
64 µg/mL (Table 1). All the carbapenem resistant 
isolates (n = 11) were phenotypically multidrug 
resistant (i.e. strains showing resistance to at least 
two groups of antibacterials), and six were ESBL 
producers. Extended spectrum beta-lactamase and 
carbapenemase producing Gram-negative bacteria 
have been reported in neonates of India (DEVI et 
al., 2018). The increase in infections associated 
with multi-drug resistant and ESBL producing 
pathogens demands the use of carbapenems. This 
might have led to the emergence of carbapenem 
resistance among organisms, and causes a challenge 
for treatment (GANDRA et al., 2016). 
The antibiogram of the CRE (n = 10) and CRP (n 
= 1) showed that the isolates were 100% resistant to 
ATZ, CTR, CAZ, CTX, CPD, CFM, and GEN. The 
isolates were also resistant to TE (9/11, 81.8%), CIP 
(9/11, 81.8%), COT (7/11,63.6%), C (5/11,45.5%), 
F/M (5/11, 45.5%) and TZP (5/11, 45.5%) (Table 
1). Resistance to sulfonamides, aminoglycosides, 
trimethoprim, tetracycline, and fluoroquinolones 
was detected in migratory avian species in Pakistan 
(MOHSIN et al., 2017). 
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The genotypic screening, targeting five major 
carbapenemase genes, showed that seven CRE and 
one CRP (blackbuck, 9B) isolates were positive 
for the blaNDM carbapenemase gene. Of the eight 
NDM positives, four CRE isolated from leopards 
were NDM-5, three CRE from leopards were NDM-
7, and one CRE from a blackbuck was a NDM-1 
variant. The blaNDM and blaAmpC gene sequences 
were submitted to GenBank, and the accession 
numbers were obtained (Table 1). Carbapenemase 
producing P. aeruginosa was reported in livestock 
animals in Lebanon (Al BAYSSARI et al., 2014). 
Carbapenem resistant blaNDM positive E. coli were 
detected in food animals and pet animals in India 
(PRUTHVISHREE et al.,2017; PRUTHVISHREE 
et al., 2018; MURUGAN et al.,2019) and wild 
black kites (FISCHER et al., 2013). Efflux pump 
mediated carbapenem resistance was noticed in 
three leopard and one blackbuck CRE isolates 
(L2, L5, L7, 2B). One CRE (L2) isolate of a 
leopard harboured both blaNDM -7 genes and an 
active efflux pump. Earlier, efflux pump mediated 
carbapenem resistance was observed in E. coli 
isolated from piglets (PRUTHVISHREE et al., 
2017). The carbapenem resistance of the isolates 
(n = 11; CRE = 10; CRP = 1) was either by means 
of carbapenem genes or active efflux pumps. 
All the carbapenem resistant and MBL positive 
isolates (n = 8) carried blaNDM genes. In the 
ESBL genotypic screening (n = 6), four isolates 
carried blaCTX-M-1 genes. In addition, blaTEM-1, 
blaAmpC,qnrA, qnrB, qnrS,tetA, tetB and sul1 
resistance genes were detected in CRE isolates. 
Carbapenem and extended spectrum beta-lactam 
co-resistance in E. coli have been reported in critical 
care human patients (JOHNSON et al., 2017) and 
blaCTX-M-1 has been reported in E. coli isolated 
from healthy animals and humans (BEN SALLEM 
et al., 2014). On Shiga toxin virulence screening, 
Stx1, Stx2 genes were detected in two and one 
isolates, respectively. E. coli isolates carrying both 
carbapenem resistance and virulence factors have 
been reported in humans, dogs and food animals 
(CANDAN and AKSOZ, 2017; PRUTHVISHREE 
et al., 2018; MURUGAN et al., 2019; VINODH 
KUMAR et al., 2019; TAMTA et al., 2020). Shiga 















1 8 16 16 Active blaNDM-7, tetA, qnrS KU318701 Inc1 ST-297
2 16 32 32 Not- active blaNDM-7, blaCTX-M-1, sul1, tetA, qnrS, stx2 KU318696 Inc1 ST-297
3 16 8 8 Not- active blaNDM-5, blaAmpC, blaCTX-M-1, tetA, stx2
KU318691, 
KU382501 Inc1 ST-297
4 8 32 16 Not- active blaNDM-5, blaTEM-1, sul1, qnrA KU318700 Inc1 ST-297
5 16 16 32 Not- active blaNDM-5, sul1, tetA, qnrS KU318698 Inc1 ST-297
6 16 32 64 Not- active blaNDM-7, sul1, tetB, qnrB KU318702 Inc1 ST-297
7 8 8 16 Not- active blaNDM-5, sul1, tetA, sxt1 KU318699 NT NT
8 32 32 16 Active blaCTX-M-1, tetB, sul1 - ND ND
9 16 16 8 Active blaCTX-M-1, sul1 - ND ND
10 32 64 8 Not- active blaNDM-1, blaAmpc, blaTEM-1 KU523520, KU382500 ND ND
11 16 16 16 Active tetA, qnrS - NT NT
R - resistant; I - intermediately resistant; S - sensitive; ATZ - aztreonam; C - chloramphenicol; CTR - ceftriaxone; CPD - cefpodoxime; 
CAZ - ceftazidime; CFM - cefixime; CTX - cefotaxime; CPM - cefepime; CIP - ciprofloxacin; COT - co-trimoxazole; ETP - 
Ertapenem; F/M - Nitrofurantoin; FOX - cefoxitin; GEN - Gentamicin; IMP - imipenem; NX - norfloxacin; MEM- meropenem; 
TE - tetracycline; TZP - piperacillin-tazobactam; ND - not done; NT - Nontypeable
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toxigenic markers were detected in 16.0% of the 
ESBL producing E. coli of piglets (NIRUPAMA 
et al., 2018). The presence of virulence markers 
and carbapenem resistance genes in E. coli isolates 
from captive wildlife is of critical importance. 
Plasmid replicon typing of CRE revealed that the 
blaNDM5 and blaNDM7 genes were harboured on 
Incl1 plasmids. The plasmid multilocus sequence 
typing (pMLST) of the blaNDM isolates displayed 
ST 297, which was also reported in the ESBL 
producing E. coli isolated from wild birds (YAHIA 
et al., 2018). Interestingly, the CRE from leopards 
harboured Incl1 plasmids carrying NDM genes and 
also a similar sequence type (ST- 297), indicating 
the transmission of resistance. Incl1 type plasmids 
were reported in ESBL producing E. coli from 
migratory avian species in Pakistan (MOHSIN et 
al., 2017), and most of the ESBL genes were carried 
on Incl1 plasmids (GARCIA-FERNANDEZ et al., 
2008). 
Conclusion
This is a prima facie report on carbapenem 
resistance in E. coli and pseudomonas in captive 
wildlife. Despite the small sample size, the 
study highlighted the emergence of carbapenem 
resistance in E. coli and P.aeurginosa isolated from 
apparently healthy leopards and blackbucks. The 
occurrence and spread of carbapenem resistance 
bacteria in captive wildlife should be a major public 
health priority. Thus, surveillance and appropriate 
measures for the control of their spread are 
extremely important.
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Sažetak
Cilj rada bio je istražiti slučajeve otpornosti bakterija E. coli i P. aeruginosa na karbapenem u zdravih antilopa 
i leoparda iz zatočeništva u Indiji. Uzorci izmeta antilopa (n = 7) i leoparda (n = 7) obrađeni su kako bi se izolirale 
bakterije E. coli (CRE) i P. aeruginosa (CRP) otporne na karbapenem. Iz uzoraka izmeta (n = 14) dobiveno je 40 
izolata (leopard n = 26, antilopa n = 14) E. coli i 2 izolata P. aeruginosa (antilopa n = 2). Pronađeno je 11 izolata 
otpornih na karbapenem, od kojih je 10 E. coli i 1 P. aeruginosa. Određena je minimalna inhibicijska koncentracija 
(MIK) za meropenem za izolate otporne na karbapenem, od 8 za E. coli i 64 μg/mL za P. aeruginosa. Svi izolati 
E. coli i P. aeruginosa fenotipski su bili otporni na širok spektar lijekova, a 6 izolata E. coli proizvodilo je beta-
laktamaze širokog spektra (ESBL). Genotipskim probirom 7 izolata E. coli i 1 izolat  P. aeruginosa bili su pozitivni na 
karbapenemaza gen blaNDM. Otpornost na karbapenem putem efluks pumpe zabilježena je u 4 izolata E. coli (36,4 
%, 4/11). Od 6 ESBL producirajućih CRE, 4 izolata nosila su gen blaCTX-M-1. Izolati E. coli također su sadržavali 
blaTEM-1, blaAmpC, qnrA, qnrB, qnrS, tetA, tetB i sul1 gene otpornosti. Pretragom na šiga-toksin, Stx1 i Stx2 geni 
utvrđeni su u dva odnosno jednom izolatu. Tipiziranje plazmida CRE otkrilo je prisutnost blaNDM gena na Incl1 
plazmidu. Multilokusno tipiziranje sekvencija plazmida (pMLST) izolata otkrilo je sekvenciju tipa (ST) 297. Pojava 
otpornosti bakterija na karbapenem u divljih životinja iz zatočeništva trebala bi biti javnozdravstveni prioritet.
ključne riječi: ESBL; E. coli; šiga-toksin; divlje životinje; otpornost na karbapenem; NDM_____________________________________________________________________________________________
